Follow-The-Filings

Security

Compass Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

7 owners 1 new 1 exit max 0.0% (Dmitry Balyasny - Balyasn...)

owners 7
max % 0.0%
tracked value $66M
qoq N 1 A 4 R 2 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Reduce 0.00 pp 1,119,090 $6M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 8,048,374 $43M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% New 0.0% 1,348,259 $7M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce -0.01 pp 846,220 $4M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 721,410 $4M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 200,428 $1M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 65,967 $349 hist
Marshall Wace - Marshall Wace, LLP exited 2026 Q1 last 2025 Q4 0.0% Exit -0.01 pp 1,263,647 $7M hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $850,000 $0.00
Gross profit
Gross margin
Net income -$42.49M -$49.38M -$66.49M
Net margin * -5808.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $153.88M $132.75M $209.82M
Total non-current assets * $2.99M $7.65M $9.77M
Total assets $156.88M $140.4M $219.59M
Total current liabilities $7.8M $8.87M $13.97M
Total non-current liabilities * $536,000 $6.3M $8.83M
Total equity $148.54M $125.23M $196.79M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$40.62M -$44.86M -$49.14M
Cash from investing $26.96M $46.77M -$93.31M
Cash from financing $2.94M $17.34M $129.61M
Net change in cash -$10.72M $19.26M -$12.84M

ownership over time

filing count by report period · click a bar for that quarter’s holders